Navigation Links
Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
Date:6/19/2009

Local Vascular Surgeon Named National Principal Investigator

PHOENIX, June 19 /PRNewswire/ -- Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System, an investigational, minimally invasive treatment for abdominal aortic aneurysm (AAA).

Leading the study efforts in the U.S. is Julio Rodriguez-Lopez, M.D., Vascular Surgeon, Arizona Heart Institute and Arizona Heart Hospital, and National Principal Investigator. "The Anaconda Stent Graft System has the potential to treat patients with infrarenal AAAs," said Dr. Rodriguez. "In commercial use outside the U.S. Phase II study, this stent graft has been shown to be flexible and repositionable. These are important features when treating patients with infrarenal AAAs," continued Rodriguez.

Abdominal aortic aneurysm, or "ballooning" of the body's main artery, is a serious condition in which the aorta is prone to rupture often causing sudden death. Studies report that emergent, open surgical repair of a ruptured aortic aneurysm carries a 25 to 50 percent risk of death; however, less invasive endovascular procedures involving stent grafts offer a lower-risk alternative to open surgical repair and are associated with minimal blood loss, faster recovery, shorter hospital stays and decreased risk of death.

"Experience with the device, which has been used commercially in nearly 4000 patients in Europe, has been very positive," said Donald B. Reid, M.D., Fellow of the Royal College of Surgeons, Consultant Vascular Surgeon, and Chairman of Vascular Surgery with Wishaw General Hospital and University of Glasgow, Scotland, U.K., who attended the procedure at Arizona Heart Hospital.

Symptoms of aortic rupture can occur suddenly with severe, sharp pain in the abdomen. Patients who experience these symptoms should seek immediate medical attention. Early detection of aortic aneurysms can prevent sudden death; therefore, patients with a family history of aortic aneurysm or other connective tissue disorders should notify their physician about their risk of aortic aneurysm.

About Arizona Heart Institute

Arizona Heart Institute (AHI) is among the world's leading providers of cardiovascular care and world authority in the endovascular treatment of aortic aneurysm and related pathologies. Founded in 1971, AHI has earned its reputation for excellence by creating a state-of-the-art medical facility that specializes in the prevention, diagnosis and treatment of heart and blood vessel disease. In the 1990s, Dr. Edward B. Diethrich, Founder and Medical Director of Arizona Heart Institute and Arizona Heart Hospital, pioneered the development of the very first stent graft for aortic aneurysms. Since then, this minimally invasive technique has become the gold standard worldwide and has changed the way vascular medicine approaches disorders of the aorta. Through dedication, education and innovation, AHI is leading the effort to eliminate cardiovascular disease and discovering new ways to save lives along the way. For more information, please visit www.azheart.com, or contact mcocco@azheart.com.

About the Study

The objective of the Vascutek Anaconda Stent Graft System Phase II IDE Study (G030036) is to assess the safety and efficacy of the Anaconda Stent Graft System in patients presenting with AAA, when compared to historical open surgical repair. The study, which is sponsored by Terumo Cardiovascular Systems, Ann Arbor, Michigan, is expected to enroll a total of 180 patients at 20 U.S. sites. The device is manufactured by Vascutek Ltd, a Terumo Company located near Glasgow, Scotland. More information can be found at clinicaltrials.gov NCT00612924.


'/>"/>
SOURCE Arizona Heart Institute and Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
2. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
3. The Well Life Center in Mesa Unveils The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
4. The Well Life Center in Mesa Continues The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
5. Neptune Society Opens Tucson, Arizona Office
6. Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza
7. NNN Healthcare/Office REIT Acquires Tucson Medical Office Portfolio in Tucson, Arizona
8. Arizona Patient Protection Act Introduced
9. Bill Germanakos and Hollie Self Bring The Biggest Loser Million-Pound Tour, Presented by MSN, to Arizona Mills Mall
10. Arizona-Based Healthy Lifestyle Corporate Events Helps Football Fans Commit to Good Health
11. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , ... May 27, 2016 , ... W.S. Badger ... announced today that it has been recognized as one of the best small businesses ... was named as one of nine small businesses providing progressive benefits to new parents ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... with Mediaplanet to help educate the many who are unaware of the plight ... to aphasia will run within the “Stroke Awareness” campaign. , The link between ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation ... providing proof of successfully certified products, services and staff. , Validation Center is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia ... negative impact on long-term patient survival, reports a team of UPMC researchers in ... week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: